Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




New Production Method for Medical-Grade Radioisotopes

By HospiMedica International staff writers
Posted on 24 Jun 2019
A novel technique enables simultaneous production of molybdenum-99 (Mo-99) and other isotopes without the need for highly enriched, weapons-grade uranium.

Developed by BGN Technologies (Beer Sheva; Israel), the technique uses the naturally occurring and stable molybdenum-100 (Mo-100) isotope and a linear electron accelerator to generate Mo-99 and technetium-99m (Tc-99m). More...
The molybdenum target acts both as a bremsstrahlung converter for the incident electron beam, and simultaneously as a Mo-99 producing target via the 100Mo(γ,n)99Mo reaction on bremsstrahlung photons. Even higher rates of molybdenum yield could be achieved by optimizing the target geometry.

The same process can also be used to simultaneously generate other short-lived radioisotopes such as 18F, 15O, 13N and 11C, which can be used as byproducts for use in positron emission tomography (PET) scans. The technology was co-developed by Alexander Tsechanski, PhD, from the department of nuclear engineering at Ben-Gurion University (BGU; Beer Sheva, Israel), and D. V. Fedorchenko, PhD, from the National Science Center Kharkov Institute of Physics and Technology (Ukraine).

“Technetium-99m is a metastable nuclear isomer of technetium-99 that is used in tens of millions of medical diagnostic procedures annually, making it the most commonly used medical radioisotope. The need for uranium and a nuclear reactor to produce this radioisotope is creating a shortage of this important substance,” said Zafrir Levy, senior vice president for business development, exact sciences, and engineering at BGN Technologies. “Tsechanski’s innovation offers a more feasible, cost-effective method, using cheaper electron accelerators for generating Mo99/Tc-99m. We are currently looking for partners for further developing and commercializing this important invention.”

The most important medical isotope, Tc-99m, is obtained from the decay of its parent Mo-99, and is used in more than 80% of all nuclear medicine procedures. Mo-99 is packed into source containment vessels and distributed to hospitals, where nuclear medicine specialists can draw off the Tc-99m as needed for about a week. Because of its unstable nature, Mo-99 does not occur naturally and is traditionally produced using nuclear research reactors powered by enriched uranium in Canada, the Netherlands, Belgium, France, Australia, and South Africa.

Related Links:

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Gynecological Examination Chair
arco-matic
Silver Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.